Lucjan Stanislaw Wyrwicz
Lucjan Stanislaw Wyrwicz publishes mostly in Oncology, Surgery and Pulmonary and Respiratory Medicine, on topics such as Gastric Cancer Management and Outcomes, Cancer Immunotherapy and Biomarkers and Esophageal Cancer Research and Treatment.
- World rank
- #235,580 of 7,710,434 ranked researchers
- Rank in Poland
- #1,475 of 100,960
- Works
- 284
- Citations
- 16k
- Citations per work
- 56.4
What does Lucjan Stanislaw Wyrwicz research?
Lucjan Stanislaw Wyrwicz's work is mostly in Medicine (61%), Biochemistry, Genetics and Molecular Biology (16%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences17361.0%
- Medicine17361.0%
- Everything else6623.3%
- Life Sciences4515.7%
- 1Oncology28% of their works
- 2Surgery15% of their works
- 3Pulmonary and Respiratory Medicine14% of their works
- 4Molecular Biology13% of their works
- 5Epidemiology4% of their works
- 6Cancer Research3% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Cancer Immunotherapy and Biomarkers
- Esophageal Cancer Research and Treatment
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Colorectal and Anal Carcinomas
- Pancreatic and Hepatic Oncology Research
- Gastrointestinal Tumor Research and Treatment
Which keywords describe Lucjan Stanislaw Wyrwicz's research?
The keywords of their largest research topics: Chemotherapy, Endoscopic Resection, Neoadjuvant Therapy, Clinical Practice Guidelines, Chemoradiation, Preoperative Chemoradiotherapy, Tumor Microenvironment and Gastric Cancer.
- Imatinib Mesylate
- Pancreatic Cancer
- Intensity-Modulated Radiation Therapy
- Adjuvant Chemotherapy
- Cetuximab
- Barrett's Esophagus
- Immune Checkpoint Blockade
- Gastric Cancer
- Preoperative Chemoradiotherapy
- Clinical Practice Guidelines
- Endoscopic Resection
- Chemotherapy
- Neoadjuvant Therapy
- Chemoradiation
- Tumor Microenvironment
- Molecular Characterization
- PD-1 and PD-L1
- Esophageal Carcinoma
- KRAS Mutations
- Anal Cancer
- Rectal Cancer
- Surgical Complications
- Sunitinib
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Chemotherapy1774 topics
- Endoscopic Resection1392 topics
- Neoadjuvant Therapy1063 topics
- Clinical Practice Guidelines1052 topics
- Chemoradiation882 topics
- Preoperative Chemoradiotherapy882 topics
- Tumor Microenvironment872 topics
- Gastric Cancer781 topic
- Molecular Characterization781 topic
- Immune Checkpoint Blockade691 topic
- PD-1 and PD-L1691 topic
- Barrett's Esophagus611 topic
- Esophageal Carcinoma611 topic
- Cetuximab541 topic
- KRAS Mutations541 topic
- Adjuvant Chemotherapy271 topic
- Anal Cancer271 topic
- Intensity-Modulated Radiation Therapy271 topic
- Rectal Cancer271 topic
- Pancreatic Cancer181 topic
- Surgical Complications181 topic
- Imatinib Mesylate141 topic
- Sunitinib141 topic
Where does Lucjan Stanislaw Wyrwicz work?
Lucjan Stanislaw Wyrwicz's main affiliation in the publication record is The Maria Sklodowska-Curie National Research Institute of Oncology, Poland.
How many publications and citations does Lucjan Stanislaw Wyrwicz have?
OpenAlex counts 284 works and 16,005 citations for Lucjan Stanislaw Wyrwicz, an h-index of 51, ranking #235,580 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Lucjan Stanislaw Wyrwicz
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lucjan Stanislaw Wyrwicz. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.